BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 19666247)

  • 1. [MELD or Maddrey?: comparison of two prognosis models in patients with alcohol toxic hepatitis].
    Zapata-Irrisón L; Jurado-Nuñez JJ; Altamirano-Gómez JT
    Rev Gastroenterol Mex; 2008; 73(2):57-62. PubMed ID: 19666247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of MELD score and Maddrey discriminant function for mortality prediction in patients with alcoholic hepatitis.
    Monsanto P; Almeida N; Lrias C; Pina JE; Sofia C
    Hepatogastroenterology; 2013; 60(125):1089-94. PubMed ID: 23803373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Model for end-stage liver disease score versus Maddrey discriminant function score in assessing short-term outcome in alcoholic hepatitis.
    Kadian M; Kakkar R; Dhar M; Kaushik RM
    J Gastroenterol Hepatol; 2014 Mar; 29(3):581-8. PubMed ID: 24117536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MELD accurately predicts mortality in patients with alcoholic hepatitis.
    Dunn W; Jamil LH; Brown LS; Wiesner RH; Kim WR; Menon KV; Malinchoc M; Kamath PS; Shah V
    Hepatology; 2005 Feb; 41(2):353-8. PubMed ID: 15660383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comparison of model for end-stage liver disease score with discriminant function and child-Turcotte-Pugh scores for predicting short-term mortality in Korean patients with alcoholic hepatitis].
    Jeong JY; Sohn JH; Son BK; Paik CH; Kim SH; Han DS; Jeon YC; Lee MH; Lee DH; Kee CS
    Korean J Gastroenterol; 2007 Feb; 49(2):93-9. PubMed ID: 17322788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combining Data From Liver Disease Scoring Systems Better Predicts Outcomes of Patients With Alcoholic Hepatitis.
    Louvet A; Labreuche J; Artru F; Boursier J; Kim DJ; O'Grady J; Trépo E; Nahon P; Ganne-Carrié N; Naveau S; Diaz E; Gustot T; Lassailly G; Cannesson-Leroy A; Canva-Delcambre V; Dharancy S; Park SH; Moreno C; Morgan TR; Duhamel A; Mathurin P
    Gastroenterology; 2015 Aug; 149(2):398-406.e8; quiz e16-7. PubMed ID: 25935634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors for mortality in patients with alcoholic hepatitis and assessment of prognostic models: A population-based study.
    Pang JX; Ross E; Borman MA; Zimmer S; Kaplan GG; Heitman SJ; Swain MG; Burak K; Quan H; Myers RP
    Can J Gastroenterol Hepatol; 2015 Apr; 29(3):131-8. PubMed ID: 25855876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MELD score is a better prognostic model than Child-Turcotte-Pugh score or Discriminant Function score in patients with alcoholic hepatitis.
    Srikureja W; Kyulo NL; Runyon BA; Hu KQ
    J Hepatol; 2005 May; 42(5):700-6. PubMed ID: 15826720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predicting short-term and long-term mortality of hospitalized Portuguese patients with alcoholic hepatitis.
    Fernandes SR; Marques da Costa P; Vítor S; Carvalho JR; Santos P; Moura CM; Cortez-Pinto H; Ramalho F; Velosa J
    Eur J Gastroenterol Hepatol; 2017 Oct; 29(10):1141-1148. PubMed ID: 28628497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The MELD Score Is Superior to the Maddrey Discriminant Function Score to Predict Short-Term Mortality in Alcohol-Associated Hepatitis: A Global Study.
    Morales-Arráez D; Ventura-Cots M; Altamirano J; Abraldes JG; Cruz-Lemini M; Thursz MR; Atkinson SR; Sarin SK; Kim W; Chavez-Araujo R; Higuera-de la Tijera MF; Singal AK; Shah VH; Kamath PS; Duarte-Rojo A; Charles EA; Vargas V; Jager M; Rautou PE; Rincon D; Zamarripa F; Restrepo-Gutiérrez JC; Torre A; Lucey MR; Arab JP; Mathurin P; Louvet A; García-Tsao G; González JA; Verna EC; Brown RS; Argemi J; Fernández-Carrillo C; Clemente A; Alvarado-Tapias E; Forrest E; Allison M; Bataller R
    Am J Gastroenterol; 2022 Feb; 117(2):301-310. PubMed ID: 34962498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Utility of the Mayo End-Stage Liver Disease (MELD) score in assessing prognosis of patients with alcoholic hepatitis.
    Sheth M; Riggs M; Patel T
    BMC Gastroenterol; 2002; 2():2. PubMed ID: 11835693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Model for end-stage liver disease-Na score or Maddrey discrimination function index, which score is best?
    Amieva-Balmori M; Mejia-Loza SM; Ramos-González R; Zamarripa-Dorsey F; García-Ruiz E; Pérez Y López N; Juárez-Valdés EI; López-Luria A; Remes-Troche JM
    World J Hepatol; 2015 Aug; 7(17):2119-26. PubMed ID: 26301054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The amount of alcohol intake, upper gastrointestinal bleeding, acute renal failure and hepatic encephalopathy as the risk factors implied in the increase of patients with alcoholic hepatitis].
    Higuera-de la Tijera MF; Pérez-Hernández JL; Servín-Caamaño AL; Serralde-Zúñiga AE; Cruz-Palacios A
    Rev Gastroenterol Mex; 2009; 74(4):306-13. PubMed ID: 20423759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The amount of alcohol consumption negatively impacts short-term mortality in Mexican patients with alcoholic hepatitis.
    Altamirano J; Higuera-de laTijera F; Duarte-Rojo A; Martínez-Vázquez MA; Abraldes JG; Herrera-Jiménez LE; Michelena J; Zapata L; Perez-Hernández J; Torre A; Gonzáles-González JA; Cardenas A; Dominguez M; Arroyo V; Ginès P; Caballería J; Bataller R
    Am J Gastroenterol; 2011 Aug; 106(8):1472-80. PubMed ID: 21556041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predicting utility of a model for end stage liver disease in alcoholic liver disease.
    Soultati AS; Dourakis SP; Alexopoulou A; Deutsch M; Vasilieva L; Archimandritis AJ
    World J Gastroenterol; 2006 Jul; 12(25):4020-5. PubMed ID: 16810751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognosis and Prognostic Scoring Models for Alcoholic Liver Disease and Acute Alcoholic Hepatitis.
    Gholam PM
    Clin Liver Dis; 2016 Aug; 20(3):491-7. PubMed ID: 27373611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. APACHE II score is superior to SOFA, CTP and MELD in predicting the short-term mortality in patients with acute-on-chronic liver failure (ACLF).
    Duseja A; Choudhary NS; Gupta S; Dhiman RK; Chawla Y
    J Dig Dis; 2013 Sep; 14(9):484-90. PubMed ID: 23692973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The presence of hepatitis B core antibody is associated with more advanced liver disease in alcoholic patients with cirrhosis.
    Zhang M; Wu R; Jiang J; Minuk GY; Niu J
    Alcohol; 2013 Nov; 47(7):553-8. PubMed ID: 24041840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nine scoring models for short-term mortality in alcoholic hepatitis: cross-validation in a biopsy-proven cohort.
    Papastergiou V; Tsochatzis EA; Pieri G; Thalassinos E; Dhar A; Bruno S; Karatapanis S; Luong TV; O'Beirne J; Patch D; Thorburn D; Burroughs AK
    Aliment Pharmacol Ther; 2014 Apr; 39(7):721-32. PubMed ID: 24612165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of four prognostic models and a new Logistic regression model to predict short-term prognosis of acute-on-chronic hepatitis B liver failure.
    He WP; Hu JH; Zhao J; Tong JJ; Ding JB; Lin F; Wang HF
    Chin Med J (Engl); 2012 Jul; 125(13):2272-8. PubMed ID: 22882847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.